Home / Stocks / LCTX

LCTX insider trading

Lineage Cell Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$6.1M
Buys · last 90 days
0 · $0
Most recent buy
2026-03-12

Cluster buy detected

4 insiders bought LCTX within a short window (2024-11-21→2024-11-26), $65k in total — cluster score 66/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-03-12Culley Brian M
President and CEO
Bought15,000$1.63$24k
2025-01-28BRADSHER NEAL C
Director · 10% owner
Bought7,894,737$0.76$6.0M
2024-11-26Howe Jill Anncluster
Chief Financial Officer
Bought15,000$0.59$9k
2024-11-26Samuel George A. IIIcluster
General Counsel
Bought15,000$0.60$9k
2024-11-25Mulroy Michael H.cluster
Director
Bought40,000$0.57$23k
2024-11-22Culley Brian Mcluster
President and CEO
Bought40,000$0.60$24k

Most active insider buyers

InsiderRoleBuysTotal bought
BRADSHER NEAL CDirector · 10% owner1$6.0M
Culley Brian MPresident and CEO2$48k
Mulroy Michael H.Director1$23k
Samuel George A. IIIGeneral Counsel1$9k
Howe Jill AnnChief Financial Officer1$9k

See LCTX on the chart

Every insider buy and sell for LCTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.